secwatch.observer — SEC 8-K summary
======================================

Issuer:     VOLITIONRX LTD (VNRX)
CIK:        0000093314
Form:       8-K
Filed at:   2024-08-12T23:59:59+00:00
Accession:  0001477932-24-004671
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

VolitionRx raises $7M in registered direct offering with milestone-linked warrants for up to $14.5M additional
--------------------------------------------------------------------------------

- Gross proceeds of ~$7M from sale of 12.7M shares/pre-funded warrants at $0.55 each; warrants exercisable at $0.57.
- Series A warrants expire 60 days after announcement of $10M+ milestone commercial agreements; series B expire 6 months after first FDA approval.
- Potential additional $14.5M if all milestone-linked warrants exercised on cash basis; no assurance of exercise.
- Net proceeds earmarked for R&D, clinical studies, product commercialization, working capital and general corporate purposes.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/93314/000147793224004671/0001477932-24-004671-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/93314/000147793224004671/vnrx_8k.htm
  HTML page:      https://secwatch.observer/filing/0001477932-24-004671

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer